Molecular Devices Corp. (MDC) is a developer of high-performance, bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems enable pharmaceutical and biotechnology companies to leverage advances in genomics and combinatorial chemistry by facilitating the high throughput and cost effective identification and evaluation of drug candidates. The Company's instrument systems are based on its advanced core technologies which integrate its experience in engineering, molecular and cell biology and chemistry. The Company currently offers three product families that address different segments of the drug discovery market: the MAXline family of microplate readers, the Cell Analysis products (which include the Fluorometric Imaging Plate Reader, or FLIPR, system, the Chemiluminescence Imaging Plate Reader, or CLIPR, system and the Cytosensor system), and theThreshold system.
(Source: 10-K) – less – More from ZoomInfo »